In Asian populations, therefore, polymorphisms of ITPA seem to be of particular relevance for the effects of mercaptopurine in children with ALL, given the low incidence of patients with variant TPMT, compared to patients of Caucasian ethnicity (Marsh and Van Booven, 2009). The gene discussed is TPMT; the disease is acute lymphoblastic leukemia.